Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, onα2 and 5-HT3 receptors

[1]  K. Starke,et al.  Subclassification of presynaptic α2-adrenoceptors: α2D-autoreceptors in mouse brain , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  B. Malinowska,et al.  Mutual interaction of histamine H3-receptors and α2-adrenoceptors on noradrenergic terminals in mouse and rat rain cortex , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  R. Eglen,et al.  5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  K. Fink,et al.  Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  K. Buchheit,et al.  Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  K. Starke,et al.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  M. Kathmann,et al.  The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of α2-adrenoceptors in the mouse brain cortex , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  H. Pertz,et al.  In‐vitro Pharmacology of Sarpogrelate and the Enantiomers of its Major Metabolite: 5‐HT2A Receptor Specificity, Stereoselectivity and Modulation of Ritanserin‐induced Depression of 5‐HT Contractions in Rat Tail Artery , 1995, The Journal of pharmacy and pharmacology.

[9]  J. Schwartz,et al.  [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors. , 1994, The Journal of pharmacology and experimental therapeutics.

[10]  P. Molinoff,et al.  International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.

[11]  T. Watanabe,et al.  Binding characteristics of a histamine H3-receptor antagonist, [3H]S-methylthioperamide: comparison with [3H](R)alpha-methylhistamine binding to rat tissues. , 1994, Japanese journal of pharmacology.

[12]  H. Timmerman,et al.  Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptor , 1992 .

[13]  A. Bast,et al.  The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: saturable and reversible binding to rat cortex membranes. , 1992, European journal of pharmacology.

[14]  J. Schwartz,et al.  Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.

[15]  G. Engel,et al.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs , 1985, Nature.

[16]  K. Starke,et al.  Functional characterization of central α-adrenoceptors by yohimbine diastereomers , 1981 .

[17]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[18]  R. Furchgott.  The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .

[19]  Van Rossum Jm.  Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. , 1963 .

[20]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.